Review
Open access
Oct 2026
Artificial Intelligence in Pancreatic Cancer: From Predictive Performance to Clinical Translation
Background: Artificial intelligence (AI) is now applied across the pancreatic ductal adenocarcinoma (PDAC) pathway, yet the literature has grown faster than the evidence needed to act on it. The question is not whether an algorithm can predict an endpoint, but whether it yields information reliable, generalizable, and...
I. Khan, A. Belhaj, A. Gemini et al.
· Cancers · 0 citations